Also, a 12-weeks saxagliptin treatment of newly diagnosed T2DM patients improved endothelial function by increasing the flow-mediated vasodilation and increasing EPCs number (CD34+CD133+KDR+) in a similar manner as metformin treatment [185]. The gene discussed is PROM1; the disease is type 2 diabetes mellitus.